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A   Area [m2] 
C   Intrinsic volume averaged concentration [kg/m3] 
C   Dimensionless concentration 
eC   Intrinsic volume averaged extracellular concentration [kg/m
3] 
iC   Intrinsic volume averaged intracellular concentration [kg/m
3] 
D    Diffusivity [m2/s] 
DOE   Degree of electroporation 
RDOE   Transient degree of electroporation 
E   Electric field magnitude [V/m] 
IE   Fraction of irreversible electroporation 
2L   L2 normalized error 
NOP   Number of solution nodes 
m   Dimensionless mass delivered to viable cells 
t   Time [s] 
pt   Time elapsed since the end of the previous electroporation pulse [s] 
X   Solution of interest 
, ,x y z   Cartesian space coordinates [m] 
v   Volume [m3] 
GREEK LETTERS 
   Porosity 
   Maximum relative difference between solutions 
R   Mass transfer coefficient of the cell membrane [1/s] 
   Cellular permeability decay constant [s] 
   Electrical potential [V] 
   Numerical damping factor 
SUBSCRIPTS  
eff   Effective 
e   Extracellular space 
i   Intracellular space 
SUPERSCRIPTS 
p   Current iteration 





This study develops a macroscopic model of mass transport in electroporated biological tissue in order 
to predict the cellular drug uptake. The changes in the macroscopic mass transport coefficient of cellular 
drug uptake are related to the empirically determined increases in electrical conductivity. Additionally, 
the model considers the influences of both irreversible electroporation and the transient resealing of the 
cell membrane associated with reversible electroporation. Two case studies are conducted to illustrate 
the applicability of this model by comparing transport associated with two electrode arrangements: side-
by-side arrangement and the clamp arrangement. The results show increased drug transmission to viable 
cells is possible using the clamp arrangement due to the more uniform electric field.  
Keywords: Electroporation, Electropermeabilization, Diffusion, Mass Transport, Mathematical 
Modeling. 
1. INTRODUCTION 
The basic structure of the cell membrane, the bilayer lipid membrane (BLM), consists of two layers of 
phospholipid molecules typically 5 nm thick [1]. The cell membrane separates the intracellular space 
(containing cytoplasm) from the extracellular space and its function is to protect the cytoplasm by 
regulating the molecular transfer. This barrier function must be overcome for the successful cellular 
uptake of a drug. Electroporation is one method that is used to overcome the cell’s barrier function by 
disrupting the structure of the membrane.  
The empirically based explanation of the electroporation of the cell membrane follows the transient 
aqueous pore mechanism hypothesis [2-4]. The transient aqueous pore mechanism involves a sudden 
localized transition to water filled pores in the membrane structure during the application of a short 
duration (1 µs to 100 ms) – high voltage electric pulse [5]. Recovery of the membrane (the transition of 
hydrophilic pores back to the BLM structure) is known to occur unless the membrane is irreversibly 
electroporated [2-4]. In some cases, the reversible electropores can be “long lived” lasting several 
minutes to hours [6, 7]. These long lasting, reversible electropores can provide the sustained 
permeability increases that are required to facilitate the relatively slow diffusion process of the transport 
of a drug into the cytoplasm. 
The introduction of the electropores is described to occur in a sequential process: the charging of the 
cell membrane, the creation of the pores, and the evolution of the pores. An excellent numerical and 
theoretical representation of the development of the electropores in single cell electroporation is 
provided in Ref [2]. The formation of these defects in bilayer membranes has also been predicted in 
simulations at the molecular scale [8-10]. The timescale associated with the initiation and evolution of 
the electropores depends on the magnitude of the electrical field, but is considered to occur at or below 
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the order of μs  [2]. Our knowledge of electroporation at the cellular level allows for the prediction (on 
an individual cell) of the number of pores, the pore sizes, and the fraction of the cell membrane that is 
occupied by these pores [2, 11].  
The challenge for researchers is to apply the understanding of this short timescale single cell behavior 
to the much slower phenomena associated with macroscale transport. In order to represent the effects 
of electroporation on macroscopic transport, the following important points that should be addressed: 
the increases in cellular permeability, the pore resealing, any cell death associated with the electric field, 
and the changes in the bulk tissue electrical conductivity during the electric pulse. 
The term irreversible electroporation refers to the situation in which the pores created by electroporation 
are unable to reseal over time [12, 13]. This non-thermal irreversible electroporation is reported to occur 
when the electric field experienced by a cell membrane exceeds a threshold value [12, 13]. The result 
of irreversible electroporation is a compromised functionality of the cell, which leads to cell death. 
While the specific mechanism for cell death is still unclear [14], it is generally accepted that the process 
of cell death is necrosis due the pores not resealing. A model that attempts to predict the cellular uptake 
of drug should also account for irreversible electroporation in regions of tissue exposed to extreme 
electric fields.  
When the transmembrane voltage is below the threshold for irreversible electroporation, the 
electropermeabilization of the cell membrane is not permanent. The complete membrane recovery 
associated with reversible electroporation has been shown to occur on a timescale of seconds to minutes 
[3] and the rate has been determined experimentally [15]. Because this process of pore resealing can 
occur on a similar timescale as macroscopic diffusion, mass transport models that are dominated by the 
process of diffusion should consider the effects of pore-resealing.  
One of the most drastic macroscale effects of electroporation concerns the increases in electrical 
conductivity of the bulk tissue [16]. The increase in electrical conductivity at the tissue level is due to 
the formation of aqueous electropores in the cell membrane. In fact, the change in the bulk tissue 
electrical conductivity is considered a good indicator of the increases in permeability resulting from 
electroporation [11, 12, 16-20]. The electroporation in biological tissue has previously been modeled 
numerically by relating the changes in the electrical conductivity to the magnitude of the electric field 
[16, 21-23].  
Addressing the modeling of drug delivery following electroporation from a macroscopic perspective is 
a relatively recent development. The 2003 study by Puc et al. [11] develops a combined theoretical-
experimental based two-compartment pharmakinetic model that relates the magnitude of cell 
electroporation to the electric field and incorporates the effects of pore resealing and cell death by 
irreversible electroporation. However, that study does not capture the macroscopic spatial variations in 
drug concentration and cellular permeability. 
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The first attempt to capture the large scale spatial responses of the delivery of drugs in electroporated 
tissue was conducted by Granot and Rubinsky in their 2008 work [24]. In that study, the authors adapt 
the model of single cell electroporation by Krassowska [2] so that it can be used to describe the state of 
the electropores as a function of the local electrical field and allows for the effects of resealing to be 
considered. This in turn is related to the ability to transport the drug from the extracellular to the 
intracellular space. The model does not consider that the electrical conductivity of the tissue is also 
related to the cellular permeability during electroporation, nor does it include the effects of cell death 
by irreversible electroporation. 
The most recent progression is the 2014 work of the Miklavčič group in Ref. [25]. This study captures 
the spatially dependent diffusion of the drug in the tissue and is the first study to thoroughly connect 
the electroporation induced permeability increases to the macroscopic transport and cellular uptake of 
the drug. This paper develops a description of the mass transport coefficient, which represents the 
permeability increases of the cell membrane that are associated with the electropores. However, that 
study assumes a uniform electric field, and the model does not include the effects of irreversible 
electroporation. 
In the present study, we extend the previous models [11, 24, 25] that relate the effects of electroporation 
to the delivery of drugs in biological tissue. We use existing empirically based relationships to predict 
the tissue electrical conductivity based on the electric field. We then use these changes in the electrical 
conductivity to quantify the increases in cellular permeability to the drug. The changes in electrical 
conductivity are also used to quantify the extent of cell death by irreversible electroporation. This study 
also considers pore resealing after the electroporation. This model is then applied to two-dimensional 
transient case studies in order to showcase the model’s ability to capture the “large scale” spatial 




2. THEORETICALLY MODELING ELECTROPORATION 
This section provides the description of a theoretical representation of electroporation and relates this 
to the transport of the drug into electroporated cells. The theoretical components presented in the 
following section are considered from a macroscopic perspective. Some of these have been previously 
developed. The distinction of this work is that the electric field dependent increases in electrical 
conductivity are used to represent the extent of permeability increases that subsequently can be used to 
predict the rate of drug exchange from the extracellular to the intracellular space. 
2.1. ELECTROPORATION 
Previous experimental and theoretical studies have shown that the extent to which cells are 
electroporated is dependent on the magnitude of the electric field resulting from the applied 
electroporation pulse [2-5, 8-16, 18-24, 26-45]. Thus, the discussion begins with the modeling of the 
electric field. In general, the Laplace equation is used to describe the distribution of the electrical 
potential:  
 ( ) 0     (1) 
where   is the electrical conductivity and   is the electrical potential. This representation has been 
supported experimentally [12, 16, 20, 23] and has been used to model the electric field associated with 
electroporation in numerous theoretical studies [12, 13, 16, 20-23, 34, 40, 44, 45]. Theoretically, Eq. (1) 
assumes the current density is divergence free: this assumption can be made if any non-Ohmic behavior 
is negligible [22, 23]. In macroscopic experimental studies, the measurable effects associated with 
electroporation (increases in electrical conductivity and permeability to ionic and molecular transport) 
are directly linked to the magnitude of electric field [12, 16, 19, 44]. The magnitude of electric field is 
simply the magnitude of the gradient in the electric potential: 
 E     (2) 
Note that the electrical conductivity of Eq. (1) is expected to increase as the cells (composing the tissue) 
are electroporated. The prediction of this change in electrical conductivity is discussed next. 
2.1.1. ELECTRICAL CONDUCTIVITY CHANGES 
At the cellular level, electroporation results in the creation of individual pores in the cell membrane. 
From a macroscopic perspective, these pores have the effect of increasing the electrical conductivity 
(measured as increases in electrical current) of the bulk tissue that is composed of these electroporated 
cells [16-18]. As the electric field increases above the onset threshold for reversible electroporation, 
more cells are electroporated. This results in a smooth saturation of electroporated cells in the tissue 
6 
 
[16]. Previous studies have considered various functional dependencies of the electrical conductivity 
on the electric field magnitude ( E ) [12, 16, 20, 22, 23]. A combined experimental and computational 
study [12] develops an empirically based sigmoidal dependency of effective electrical conductivity on 
the magnitude of the electric field that is depicted in Fig. 1 and represented as: 
 





























  (3) 
In this approximation, the term 
revE  represents the onset threshold electric field magnitude for reversible 
electroporation. This is the minimum electric field magnitude required for any reversible 
electroporation to occur. Below this value, the electric field is not sufficient to initiate any 
electroporation. The term 
irrevE  refers to the onset threshold electric field magnitude required for 
irreversible electroporation (or the onset of a loss in cell viability). The value of 
irrevE  can be found 
experimentally by determining the onset at which cell necrosis is observed. For example in section 2.4 
of the paper by Miklavčič et al. [46] an explicit description of evaluating the threshold of the electric 
field magnitude at which rabbit liver cells begin to experience necrosis. Below this value, there is no 
irreversible electroporation of the cells. The value of the effective tissue electrical conductivity in the 
absence of any electroporation is denoted 
min . The maximum possible effective electrical conductivity 
of the tissue resulting from electroporation is denoted
max . The symbols   and   are the sigmoidal 
functional parameters. The parameter values of Eq. (3) are dependent on the tissue and can be 




Fig. 1. The dependence of the electrical conductivity (Error! Bookmark not defined.) on the 
magnitude of the electric field ( E ) represented by Eq. (3) and simultaneously the degree of 
electroporation ( DOE ) represented by Eq. (4). 
The state of tissue electroporation can be characterized by four key stages: (I) no electroporation, (II) 
reversible electroporation, (III) irreversible electroporation, and (IV) complete irreversible 
electroporation. These stages of tissue electroporation may be related to the electrical conductivity 
shown in Fig. 1. Stage I refers to no measurable increase in electrical conductivity and thus no 
electroporation. Stage II is where the distribution of cells composing the tissue are being electroporated 
to a reversible extent, significantly increasing the electrical conductivity. The extent of reversible 
electroporation increases smoothly due to the distribution of cell size resulting in a varying 
transmembrane voltage [47]. Stage III is past 
irrevE  (onset of loss of cell viability) resulting in a fraction 
of irreversibly electroporated cells [16]. In this stage of irreversible electroporation, the electrical 
conductivity begins to plateau as the electric field is increased, due to the electroporation approaching 
the limit. The limit refers to the magnitude of electric field where the entire population of cell subjected 
are irreversibly electroporated (
maxE ) - stage IV. Beyond maxE  no further alteration in the electrical 
conductivity takes place. 
2.1.2. DEGREE OF ELECTROPORATION 
In order to relate the effects of electroporation to the increases in cellular permeability, it is first 
necessary to quantify the extent to which the cells are electroporated. It is generally accepted that the 
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increases in the electrical conductivity are directly representative of the extent to which cells in the 
tissue have been electroporated [16-18]. This is because the increases in measured electrical 
conductivity are a consequence of the introduction of aqueous pores in the cell membrane. We next 
relate the extent of cellular electroporation to the increases in the electrical conductivity by a function 











  (4) 
In this way, the DOE  (also depicted in Fig. 1) follows the same smooth dependency on the magnitude 
of the electric field as the effective electrical conductivity. A zero value of the DOE  indicates that no 
electroporation has occurred, and a DOE with the value unity indicates that no further electroporation 
can occur. From the macroscopic perspective and in the context of this study, the degree of 
electroporation can be interpreted as the link between the electric field and the increases of the cells’ 
permeability to mass transport. This idea is revisited in the development of the mass transport model.  
2.1.3. IRREVERSIBLE ELECTROPORATION 
When the electric field magnitude is sufficiently high, the electroporation pores in the cell membrane 
are permanent and do not reseal over time. Irreversible electroporation causes cell death because it 
compromises the functionality of the cell [13, 14, 36, 37, 40, 41, 45]. It is necessary to quantify the 
extent of irreversible electroporation as it influences the membrane pore resealing and represents the 
extent of cell death. In the theoretical study Ref. [11] a function named the “survival fraction” is 
introduced to represent the effects of irreversible electroporation, following a sigmoidal dependence on 
the magnitude of electric field. Similarly, in this, study we consider once more the idea that the changes 
in the macroscopic electrical conductivity can be considered to directly represent the averaged state of 
the electropores in the cell membranes. Note that in stage III of Fig. 1, as the electric field magnitude (
E ) exceeds the onset of irreversible electroporation ( irrevE ), the electrical conductivity asymptotically 
approaches its maximum value (
max ). The physical interpretation of the limiting-off effect is that as 
more of the electropores have reached their irreversible state (limit of electroporation) the electrical 
conductivities sensitivity to the change in electric field reduces. Since this process is so well reflected 
by the electrical conductivity, in this paper the extent of irreversible electroporation is quantified by the 
state of the electrical conductivity. Introducing a term called the fraction of irreversible electroporation 
( IE ) represented by: 
  
max
0                     for 
( )






















irrev  is the value of the electrical conductivity corresponding to the magnitude of the electric 
field at the onset threshold for irreversible electroporation (
irrevE ) and the electrical conductivity in the 
numerator is evaluated from Eq. (3). This function is depicted in Fig. 2. An IE  value of unity represents 
completely irreversibly electroporated tissue and a value of zero indicates that the electric field is below 
the threshold 
irrevE  and that none of the cells are damaged.  
Considering that
irrevE  corresponds to the onset of cell death ( 0IE  ) and maxE  corresponds to the 
magnitude of electric field where the entire population of cells subjected are irreversibly electroporated 
( 1IE  ); Eq. (5) provides a first order approximation of the fraction of irreversible electroporation  
( IE ) using the changes in electrical conductivity between these two parameters ( irrevE  and maxE ). This 
approximation (Eq. (5)) should be experimentally validated, but for the purposes of this representative 
study it provides valuable insights. Ideally, the fraction of irreversible electroporation ( IE ) could be 
redefined by empirically relating it directly to the magnitude of electric field, like  the “survival fraction” 
developed in Ref. [11]. 
 
Fig. 2. The dependence of the fraction of irreversible electroporation ( IE ) (thick line) on the magnitude 
of electric field ( E ). The fraction of irreversible electroporation is approximated by Eq. (5) using the 
electrical conductivity (Eq. (3)) at values above the electrical conductivity associated with the onset of 




2.1.4. PORE RESEALING: THE TRANSIENT DEGREE OF ELECTROPORATION 
When cells are reversibly electroporated, they return to their original state over time [15]. Pore resealing 
is observed experimentally as a relaxation in the increases in the cell permeability associated with 
electroporation. The effects of reversible electroporation have been shown to diminish exponentially in 
time [30, 47-49]. In order to account for the transient resealing of the reversibly electroporated cells as 
well as the permanently irreversibly electroporated cells, the transient degree of electroporation is 
defined by the relation: 
       ( , ) 1 exp pR
t
DOE E t DOE E IE E IE E

  
        
  
  (6) 
where pt  is the time after the end of the previous electroporation pulse, and  is the time constant for 
cell permeability relaxation (due to pore resealing) which may be determined experimentally. The 
DOE  is evaluated from Eq. (4) and the IE  is evaluated from Eq. (5). It should be noted that the 
magnitude of IE  at a specific location can never decrease. 
In the case of multiple electroporation pulses, the state of the electrical conductivity due to a previous 
electroporation pulse may also need to be considered. As the cells reseal, the electrical conductivity will 
also return to its original value. This can be addressed by relating the electrical conductivity to the 
transient degree of electroporation (
RDOE ): 
  max min minR RDOE         (7) 
where 
R  is the electrical conductivity of the tissue. The implementation of the electrical conductivity 
into the electric potential distribution solver is discussed later.  
The transient response of the bulk tissue conductivity is captured in Eq. (7) through the reversible degree 
of electroporation (
RDOE ). The resealing of the electropores is addressed in Eq. (6) using an empirically 
determined time constant, so that the transient effect should be well represented in Eq. (7). The 
expression also considers that the irreversibly electroporated cells have no contribution to the transient 
electrical characteristics of the tissue. However, it should be noted that while the nature of this recovery 
is experimentally based, the magnitudes reflected by Eq. (7) have not been experimentally validated. 
The motivation behind the attempt to quantify the magnitude of the electroporation and capture the 
effects of the pore resealing of Eq. (6) is ultimately to attempt to couple the effects of electroporation 
to the cellular uptake of the drug and to the general drug transport. The following sections describe the 




2.2. MASS TRANSPORT IN ELECTROPORATED TISSUE 
In this section we will relate the transient degree of electroporation (
RDOE ) to the mass transport. We 
first consider that from a macroscopic perspective the tissue may be considered to be a composition of 
two distinct regions: 
1) The extracellular space that composes the space outside the cells. This extracellular space is a 
continuous space containing the extracellular matrix structure, which provides the support 
structure for the surrounding cells. The interstitial fluid occupies the rest of the extracellular 
space [50]. 
2) The intracellular space that represents the sum of all the discreet volumes that are encompassed 
by the individual cell walls. The intracellular space is the target of cellular drug delivery. 
The two spaces, the extracellular and the intracellular, are separated by the cell membrane (Fig. 3). The 
cell membrane restricts the mass transfer from extracellular to intracellular space: the cellular drug 
uptake. Note that the drug is free to travel by diffusion throughout the extracellular space as it is 
continuous, however, once it arrives in the intracellular space, the drug is restricted from freely diffusing 
through the domain by the cell wall. The drug concentration in the extracellular space is denoted 
eC  
and the drug concentration in the intracellular space is denoted
iC . These concentrations are 
macroscopic properties which are determined using the intrinsic volume averaged concentration [51]. 
This description is a porous media representation of the tissue where the fluid filled extracellular space 









  (8) 
Figure 3 shows the volumes of interest, where ve  is the extracellular space volume and vi  is the 




Fig. 3. A representation of the extracellular and intracellular space, cell membrane, and membrane 
pores. 
The coupled extra-intracellular transport model used in this study follows the one developed by the 
research group of Miklavčič in ref. [43]. The concentration of the drug in the extracellular space (
eC ) 
is governed by:  
 
1
( ) ( )e eff e R e i
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    

 (9)  
where effD  is the effective diffusion coefficient of the drug in the extracellular space, which is either 
determined experimentally or approximated using the extracellular space tortuosity of the tissue  
[43, 51, 52]. The mass transfer coefficient, 
R , is associated with the condition of the cell membrane, 
and  governs the rate of cellular drug uptake. The last term of Eq. (9) represents the rate at which the 
drug leaves the extracellular space due to the cellular drug uptake. This is a diffusive process that occurs 
through the pores within the cell membrane, which separates the extracellular space from the 
intracellular space (see Fig. 3).  
The drug concentration within the intracellular space is governed by:   








  (10) 
Note that Eqs. (9) and (10) do not consider the effects of partitioning, absorption, metabolism, or 
clearance [51]. Electrophoresis and electro-osmosis during the application of the electric pulse are also 
not considered in the development of this model. 
The mass transport coefficient, 
R , of Eqs. (9) has previously been formally defined by the Miklavčič’s 
research group in Ref. [43]. In that study it is logically posed that the permeability of the cell membrane 
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to the solute (the magnitude of the mass transport coefficient) is directly proportional to the total area 
of all pores in the cell membrane. This is a very helpful contribution because the electroporation related 
increases in the total pore area can now be directly related to increases in the mass transport coefficient. 
It is the purpose of the current study to extend this idea in order to directly relate the drug uptake to the 
electroporation induced electric field. Recall that the transient degree of electroporation defined in Eq. 
(6) was developed in order to reflect the state of the cellular permeability after electroporation. With 
this in mind, we consider a simple linear dependence of the mass transport coefficient on the transient 
degree of electroporation (
RDOE ):  
 max 0 0( )R RDOE         (11) 
where 
max  corresponds to the magnitude of the mass transfer coefficient when the cell is fully 
electroporated ( 1RDOE  ). The parameter 0 represents the mass transfer in the case that the cells 
have experienced no electroporation ( 0RDOE  ); it is probably negligible for larger solutes. The 
cellular uptake mass transfer coefficients (
max and 0 ) are highly dependent on the solute, the cell type, 
and the electroporation parameters. Experimental measurements could be used in order to determine 
these values for a given solute, tissue, and pulse characteristic. A theoretical approximation of the 
parameters, 
max and 0 , is used based on the theoretical development of the mass transfer coefficient 
in Ref. [43]. 
It is important to note that the accuracy of Eq. (11) in predicting the behavior of the cells’ permeability 
to molecular transport depends on how well the empirically derived transient degree of electroporation 
(
RDOE  which is based on the bulk electrical behavior of the tissue) represents the state of the cell 
membrane. Expression (11) assumes that the rate of cellular recovery associated with the permeability 
of mass transport across the cell membrane is the same as that of the long term electrical recovery of 
the cell membrane. While in principle the mechanics are the same (both are associated with the resealing 




3. NUMERICAL MODEL 
A numerical model is developed to illustrate the applicability of the theoretical model described in 
Section 2.  The numerical model considers the evaluation of Eqs. (1)−(11) in a two dimensional domain. 
Two test cases are considered that are representative of two different electrode arrangements. In this 
section we discuss the numerical handling of the model. 
3.1. GENERAL COMPUTATIONAL CONSIDERATIONS 
The solutions of the governing Eqs. (1), (9), and (10) are approximated numerically using the finite 
volume approach. The transient equations governing the concentrations, Eqs. (9) and (10), are 
represented using a fully implicit scheme. The resulting discretized systems of equations are solved 
using the successive over-relaxation (SOR) method [53] where the convergence is determined from the 





















  (12) 
where ( )
pX i is the solution from the current iteration of the conserved variable  ,  ,  or i eC C  and 
1( )pX i corresponds to that of the previous iteration. The integer i  corresponds to the node number and 
NOP  is the number of nodes. Convergence is reached when 1010  .  
A grid is used with increased refinement in regions of the domain where electroporation occurs, 
allowing the solution to be determined significantly faster without compromising the accuracy. To 
ensure the independence of the solution from the grid and time step used, grid and time-step 
independence studies were conducted. An L2 normalized error, symbolized by
2L , was used to estimate 





























  (13) 
The resolution of the rectilinear grid was refined until an L2 error norm (
2L ) value of less than 0.001 
was reached. This resulted in the number of spatial grid nodes provided in Table 2 for the cases modeled. 
Two time step sizes were considered: a larger time step size was used for the mass transport prior to the 
electroporation and a smaller time step size was considered after the initial electroporation pulse. The 
time step sizes were halved until an error (
2L ) value of less than 0.001 was reached, resulting in the 
time step sizes provided in Table 2. 
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In order to verify the numerical handling of the conservation Eqs. (1) and (9), a comparison study is 
conducted of the numerical solution to a known analytical (exact) solution. A simple test case of a 
square region is depicted in Fig. 4: this has been amended from the problem presented in section 3.2.1 
of the book Ref. [54]. The numerical solutions were evaluated for a square region with 40804 nodes. 
The numerical handling of the steady potential distribution is solved with a constant electrical 
conductivity, one inhomogeneous boundary, one homogenous boundary condition, and two insulated 
boundaries, as outlined in Fig. 4a. The numerical solution is then compared to the exact solution that is 
provided in Table 3.26 of reference [54]. The resulting error ( 2L ) is less than 0.0012. 
 
Fig. 4. The simplified case for verification of the numerical solver using the analytical solution. Where 
(a) is for the steady state electric potential ( ) distribution and (b) is for the transient concentration (C) 
distribution (where 0R  ). The analytical solutions to these problems are provided in Ref. [54] 
To verify (in part) the numerical handling of the extracellular concentration of Eq. (9) the simple 
transient case represented by Fig. 4b is considered. This consists of one inhomogeneous boundary, one 
homogenous boundary, two boundaries that are insulated to mass transport, and a zero initial condition. 
This requires that the mass transport coefficient of Eq. (9) be set to zero: 0R  . The exact solution to 
this problem is provided in Table 3.2.6 of Ref. [54]. The numerical solution was evaluated using a time 
step size of 10  s. Again the L2 normalized error (
2L ) is used to compare the numerical solution to the 
exact solution. The transient error is depicted in Fig. 5 with the anticipated exponential decay that 
approaches an error (
2L ) of less than 0.0012. These results indicate that the solution is being solved 




Fig. 5. The transient behavior of the normalized error (
2L ) of Eq. (9)  (where 0R  ) compared to the 
corresponding exact solution presented in Table 3.26 of Ref. [54] 
3.2. NUMERICAL HANDLING OF THE CONSERVATION EQUATIONS  
Recall that Eq. (1) which governs the electric potential is nonlinear due to the dependence that the 
electrical conductivity has on the magnitude of the electric field (described by Eq. (3)). The 
computational handling of this nonlinearity is the focus of a number of studies [16, 21-23]. The most 
common method for determining the electric field distribution is the sequential analysis developed in 
Ref. [16]. However, in the comparison study of different methods in Ref. [23] it is shown that the 
nonlinear parametric analysis method (developed in Ref. [22]) provides a similar prediction of the 
electric field during tissue electroporation. 
In this paper, the electric field is evaluated using the algorithm as shown in Fig. 6. The essence of this 
iterative approach is that the electrical conductivity is determined from the electrical field magnitude 
based on the potential distribution of the previous iteration. Note that this method allows the electrical 
conductivity to decrease during the iterative procedure, depending on the electric field magnitude. The 
final solution is achieved when the residual of the coupled electric potential and electrical conductivity 
Eqs. (1) and (3) is at a minimum. To help achieve convergence (solver stability), updating of the 
conductivity between iterations requires numerical damping: 
    1 1, ( ) 1p p pE E             (14) 
where p  is the updated conductivity, 1p  is the conductivity from the last iteration, ( )E  is 
evaluated using Eqs. (2) and (3), and   is the numerical damping factor. The damping factor value 




Fig. 6. The algorithm representing the iterative solving process used to determine the electric potential 
distribution and electrical conductivity for the electroporation pulse. 
When solving for the first electroporation pulse (Fig. 6) the initial electrical conductivity is equal to the  
tissue in its normal state: no electroporation (
int min  ). For the case of multiple electroporation pulses 
the initial electrical conductivity is determined using Eq. (7) (
int R  ). Note that when solving for the 
electric potential distribution (Fig. 6) the electrical conductivity should not be allowed to reduce below 
this initial value ( int
p   ). 
The conserved variables (
eC , iC  and  ), electrical conductivity ( ), and electric field magnitude  
( E ) are evaluated at the cell centers. Due to the varying electrical conductivity ( ) the effective 
conductivity between cells is determined using a harmonic mean [55]. The electric field magnitude  
( E ) of Eq. (2) is evaluated at the cell centers using an estimation of the electric potential ( ) at the cell 
interfaces using the conservation of flux. The degree of electroporation ( DOE  ) and the fraction of 
irreversible electroporation ( IE ) are evaluated based on the electrical conductivity (  ). The 
conservation of intracellular (
iC ) and extracellular concentration ( eC ) are evaluated simultaneously 
using the transient mass transfer coefficient associated with the cellular uptake ( R  - Eq. (11)) 
determined using the 
RDOE  evaluated at the current time step ( t ). Two types of boundary conditions 
(BC) are considered: Dirichlet BC (specified value) and zero flux Neumann BC (insulated). 
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3.3. CASE STUDIES 
The two test cases considered in this study differ in electrode configuration: Case (1) is a parallel plate 
or side-by-side arrangement (Fig. 7a) and Case (2) is a clamped electrode arrangement (Fig. 7c). In both 
cases, the drug is introduced by a carrier gel that is applied to a single surface of the tissue as depicted 
in Fig. 7b and Fig. 7d. 
The parameter values used in this study are provided in Table 1 and have been estimated to reflect the 
transport of calcien in liver tissue. Calcien was chosen for this study because its hydraulic radii and 
transport properties are well known [56]. The topical gel applied containing the calcien is assumed to 
have a diffusion coefficient of calcien in water at 37 °C.  
The two cases are considered in a three stage process:   
i. The pre-pulse diffusion stage: This consists of a one hour period during which drug is 
free to diffuse into the tissue from a topical applicator gel. Mass transport Eqs. (9) and 
(10) are evaluated numerically with 0R  .  
ii. The electroporation pulse stage: Here the electroporation of a 100 μs duration pulse 
and its effects are modeled by solving Eqs. (1) - (5). At the conclusion of this stage the 
parameters DOE  and IE  have been established. 
iii. The post-pulse diffusion stage: This consists of a ten minute long stage that accounts 
for the cellular uptake of the drug. Negligible cellular uptake occurs to living cells after 
ten minutes as resealing is approximately complete. During this stage the mass 
transport Eqs. (9) and (10) are evaluated numerically where the mass transport 
coefficient is numerically evaluated using Eqs. (6) and (11) at each time step. 
Note that the electric pulse duration (stage ii) is specified as it is experimentally observed to influence 
the rate of cell permeability relaxation ( ) [48] and cell permeability to mass transport [38], but does 
not affect the evaluation of the steady state electric potential distribution (Eq. (1)). 
The cases modeled both consist of a 2D domain composed of a simple homogenous section of liver 
tissue (Fig. 7). These cases described are for representative purposes and it should be noted that this 
model is not restricted to two dimensions, macroscopically homogenous tissue, or liver tissue 
specifically. The model uses a no-flux boundary condition on all the external surfaces of the domain in 
Fig. 7. For the electrical potential distribution this condition is justifiable if the boundaries are 
sufficiently far from the applied potential difference, not restraining the natural flow of electric current 
[13, 16]. Similarly, for drug transport, the boundaries are required to be sufficiently far from the drug 
source to have negligible influence on the drug diffusion. Thus, the domain used (Table 2) result in a 




Fig. 7. Geometry of the two cases being modeled: Case (1) with both electrodes positioned on the 
surface and Case (2) with a clamped electrode configuration. (a) and (c) show the electric pulse setup 
and (b) and (d) show the drug gel applied to the top surface for Case (1) and (2) respectively. 
3.4. MODEL PARAMETERS 
The mass transfer coefficients related to cellular uptake (
max 0 and   ) are approximated for the 
purposes of this study using the theoretical electroporated cell representation developed by Miklavčič’s 
research group in Ref. [43]. The resulting parameter values are provided in Table 1 for liver tissue 
consisting of hepatocyte cells which can be represented by a cube of equal side lengths [57]. 
For the case studies the diffusivity of calcien in the topical gel ( gelD ) is approximated by the diffusivity 
of calcien in water at 37 °C (
0D ) - determined theoretically using the Stokes-Einstein relation [56, 58]. 
The diffusivity of calcien in liver tissue ( effD ) is approximated theoretically using the free diffusivity 
of calcien in a dilute solution of water (
0D ) and taking into account the tortuosity of the porous structure 
[51, 52]. However, this diffusivity ( effD ) neglects the interaction between the calcien and the 
extracellular structures [50]. The diffusivities determined provide an order of magnitude estimate, with 
a diffusivity of calcien in liver tissue comparable to that of the experimentally measured diffusion 
coefficient of calcien in brain tissue and a free diffusivity similar to the experimentally determined value 




Table 1. Material Properties and Parameters (liver tissue) 
Symbol Description Value Reference 
revE  Onset threshold for reversible electroporation 460 V/m [16] 
irrevE  Onset threshold for irreversible electroporation 700 V/m [16] 
min  Tissue electrical conductivity with no electroporation 0.067 S/m [16] 
max  Maximum electrical conductivity due to electroporation 0.241 S/m [16] 
  Sigmodal functional parameter 8 [16] 
  Sigmodal functional parameter 10 [16] 
gelD  Diffusivity calcien in gel (~calcien in water at 37 °C) 3.8×10
-10 m2/s [56] 
effD  Effective diffusivity of calcien in liver tissue 2.5×10
-10 m2/s [52, 56] 
  Volumetric porosity fraction 0.18 [61] 
  Permeability decay time coefficient 100 s [48] 
0  Minimum mass transfer coefficient of the cell membrane 0 1/s [43] 
max  Maximum mass transfer coefficient of the cell membrane 9.4×10
-5 1/s [1, 2, 26, 38, 43, 62] 
 
Table 2. Model Parameters and Setup 
Symbol Description Case (1) Case (2) 
V0 Applied voltage 480 V 350 V 
gelC
CGEL 
Initial drug concentration in the gel 1 kg/m3 1 kg/m3 
d Tissue thickness 10 mm 5 mm 
w Domain width 100 mm 100 mm 
lelec Distance between electrodes 5 mm 5 mm 
welec Width of electrodes 20 mm 20 mm 
thgel Gel thickness 10 mm 10 mm 
wgel Gel width 50 mm 50 mm 
tpre Pre-pulse diffusion duration 3600 s (1 hour) 3600 s (1 hour) 
tpost Post initial pulse diffusion duration 600 s (10 minutes) 600 s (10 minutes) 
NOP  Number of spatial domain nodes  47306 110888 
dtpre Time step size for  the pre-pulse diffusion 10 s 10 s 
dtpost Time step size for the post-pulse diffusion 0.1 s 0.1 s 
3.4. NONDIMENSIONALISATION 
To study the mass transport in the system, the drug concentrations were nondimensionalized using the 
















4. RESULTS AND DISCUSSION 
4.1. PRE-PULSE DRUG DIFFUSION 
Allowing the drug to diffuse into the tissue prior to the electroporation pulse, for a duration of an hour, 
results in an increase in extracellular drug concentration (
eC
 ). The pre-pulse diffusion period (stage i) 
is critical as it allows the drug to diffuse into the tissue so that the extracellular drug concentration  
(
eC
 ) is high in the region of tissue where it is later electroporated (stage ii). Figure 8 shows the 
extracellular concentration (
eC
 ) contours from pre-pulse drug diffusion for both Case (1) and (2)  
(Fig. 7). Note that a significant amount of drug diffuses into the extracellular space at the top of the 
tissue. 
 
Fig. 8. Pre-pulse extracellular drug concentration (
eC
 ) after leaving the drug to diffuse into the tissue 
for a duration of an hour for both Case (1) and (2). 
4.2. ELECTROPORATION PULSE 
An electrical pulse applied to the tissue, directly after the pre-pulse diffusion process, results in 
electroporation. Figure 9 shows the electric field magnitude ( E ) and the degree of electroporation  
( DOE ). Figure 10 shows the fraction of irreversible electroporation ( IE ). For Case (1), a comparison 
of Fig. 9b and Fig. 10a shows a large portion of highly electroporated tissue is irreversibly 
electroporated and therefore dead. Case (1) produces a non-uniform distribution in electric potential 
resulting in a varying electric field magnitude ( E ) and thus large changes in the DOE  (Fig. 9a and 
Fig. 9b). Whereas Case (2) results in a more uniform distribution in electric potential producing a region 
of highly and reversibly electroporated tissue ( 0.9DOE  ) - Fig. 9d. It is observed in Fig. 9 that 
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electroporation only occurs between the electrodes for both cases. This results in a smaller 
electroporated region for Case (1) (Fig. 9b). 
  
 
Fig. 9. An electric potential is applied between the electrode (+V0) and the ground for a duration of 100 
µs resulting in electroporation of the liver tissue. (a) and (c) show the magnitude of electric field ( E ) 
[kV] and (b) and (d) show the subsequent degree of electroporation ( DOE ). The dashed boxes 
correspond to the sections depicted in (b) and (d) as well as in Fig. 10 and Fig. 12. Symmetry occurs 
about the z  axis at 0x  for both Case (1) and (2) and about the x  axis at  2.5 mmx  for Case (2). 
4.3. POST-PULSE DRUG DIFFUSION 
Drug transport in the tissue is considered for ten minutes after the electroporation pulse. Negligible 
cellular uptake occurs after ten minutes into reversibly electroporated cells due to cell resealing. 
Recalling that the main purpose of the electroporation is to increase the cellular drug uptake, Fig. 10 
shows the intracellular concentration (
iC
 ) and the fraction of irreversible electroporation ( IE ). The 
concentration gradient between extracellular and intracellular space due to the pre-pulse drug diffusion 
combined with increased cellular permeability ( R ) allows significant cellular uptake to occur. The pre-
pulse drug diffusion is therefore critical in the transmission of the drug to the cells as resealing occurs 
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relatively quickly. Unfortunately, in Case (1) (Fig. 10a) a large portion of the region where cellular drug 
uptake occurs has been irreversibly electroporated ( IE ). Case (2) provides a more optimal electrode 
setup for cellular drug uptake to living cells, where cellular uptake occurs in a larger region of tissue 
with a smaller fraction of this region being irreversibly electroporated (Fig. 10b). 
 
 
Fig. 10. After the single electroporation pulse the drug transport is considered for another 10 minutes 
with the applied drug gel removed. The increased rate of cellular uptake due to electroporation results 
in an increased intracellular drug concentration (
iC
 ). Above the onset threshold of irreversible 
electroporation, the electric pulse results in a fraction of irreversible electroporation ( IE ). 
The numerical values of cellular drug uptake are significantly larger in regions where irreversible 
electroporation occurs. This is because cell resealing significantly hinders the cellular uptake to living 
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cells. The application of multiple pulses spaced at intervals (periodic electroporation) would reduce the 
influence of pore resealing allowing cellular uptake to continue to occur.  
4.4. PERIODIC ELECTROPORATION 
Consider momentarily that the reversible portion of the transient degree of electroporation in Eq. (6), 
which is used to determine the cellular permeability in Eq. (11), has a time dependent exponential decay 
term. Equation (6) is rewritten here for clarity: 
       
 













  (17) 
where the exponential decay in cellular permeability associated with pore resealing is labeled as the 
resealing component, and pt  corresponds to the time elapsed since the end of the previous pulse. 
In this section we consider that the negative effect of pore resealing on delivery to cells can be 
moderated by implementing an electroporation pulse train so that the pores do not have the ability to 
fully reseal. Figure 11 illustrates the behavior of the resealing component (Eq. (17)) for a single pulse 
and for a train of pulses with a pulse spacing of 10 seconds, considered for a duration of 10 minutes. 
 
 
Fig. 11. The transient behavior of the resealing component of the transient degree of electroporation 
(Eq. (18)) for a single application of electroporation and for a pulse train where the tissue is 
electroporated periodically. The pulse train considered is applied for the entire 10 minutes with a pulse 




It is clear that the pulse train reduces the influence of pore resealing on the state of cellular permeability. 
With this in mind, we now present a study of Case (1) and (2) in which instead of a single pulse, pulses 
are administered at 10 second intervals over 10 minutes. After 10 minutes the final intracellular drug 
concentration (
iC
 ) was evaluated and presented in Fig. 12 for both cases. The comparison of Fig. 12 
to the previous cases using a single application of electroporation (Fig. 10) highlights the large increase, 
approximately fivefold, in intracellular drug concentration (
iC
 ) in the reversible region ( 0.1IE  ) due 






Fig. 12. After the first electroporation pulse of the pulse train the drug transport is considered for another 
10 minutes with the applied drug gel removed. A pulse train with a pulse spacing of 10 seconds was 
applied for the entire 10 minutes in which drug transport was considered. The resulting intracellular 
drug concentration (
iC





It is very apparent from the previous results that cellular drug uptake to living cells is limited by 
irreversible electroporation as it causes cell death. A study is conducted to determine the optimal pulse 
voltage when considering drug uptake to living cells, using the previously described cases where 
electroporation is applied periodically. In order to quantify the drug transported to living cells the 
dimensionless total drug mass in viable cellular space (
im
 )  is approximated by evaluating the integral 
of the intracellular drug concentration (
iC
 ) over the domain for the portion of the tissue that is not 
irreversibly electroporated (  1 IE  - viable portion): 








m t C IE dxdz 
 
       (19) 
where the porosity term  1   accounts for the use of the intrinsic volume averaged concentration  
(
iC
 ) [51]. It is noteworthy to point out that Eq. (19) only considers the component of the mass that has 
been delivered to the viable living cells. 
Equation (19) enables the total mass in viable cells (
im
 ) to be approximated for a specific case, 
allowing cases to be quantitatively compared and optimized. Following this logic a parametric study is 
considered; simulating the case studies using different applied voltages, in order to determine the 
optimal applied voltage when considering the maximization of 
im
  (Eq. (19)). Subsequently, the results 
for Case (1) and (2), using the periodic application of electroporation, are presented in Fig. 13, where 
the optimal voltage corresponds to the peak in the total drug mass in living cells (
im
 ). Clearly there 
seems to be an optimal voltage for each case (Case (1) ~ 480 V and Case (2) ~ 350 V). This is because 
as the magnitude of the applied electric field is increased, more cells are electroporated which results 
in more mass delivered to the viable cells. However, as the magnitude of the applied electric field is 
further increased, the portion of cells that is irreversibly electroporated increases.  
The maximum total drug mass in living cells (
im
 ) for Case (2) is approximately five times larger than 
Case (1) due to the significantly larger region of electroporation and cellular uptake with a smaller 
fraction of this region being irreversibly electroporated (Fig. 10). Case (2) gives an optimal voltage 
when the extent of tissue electroporation is high, but still within the limits of reversibility ( 0.9DOE 
, near the onset of irreversible electroporation, Eirrev) - shown in Fig. 10b. Thus, the optimal voltage 
peak is also considered to be closely related to the maximization of reversible electroporation  




Fig. 13. The computed total mass in living cellular space (
im
 ) at different applied voltages using 
periodically applied electroporation every 10 seconds for a duration of 10 minutes (pulse train). The 
voltages resulting in the maximum cellular uptake to living cells for both cases (Case (1) ~ 480 V and 
Case (2) ~ 350 V) are used for the previously modeled results (Table 2). 
5. CONCLUSION 
This paper develops a macroscopic model of drug transport into biological tissue which is 
electroporated in order to increase cellular drug uptake. The model considers that the electrical 
conductivity of the tissue (which is easily measured) is a good indicator of the presence and state of the 
electropores at the cellular level. The model is based on the hypothesis that the 
RDOE , which is based 
on the behavior of the tissue electrical conductivity, can be used to represent the state of cellular 
permeability to drugs.  
While the model is primarily based on empirical observations, some of the relationships have not been 
fully established experimentally. The fraction of irreversibly electroporated cells in our model is 
evaluated from the electrical behavior of the tissue. The result approximates what is observed 
experimentally [11], however, further work is required to validate the accuracy of the relation. 
Furthermore, while the limits of the mass transfer coefficient (
R ) are approximated theoretically in 
this study using experimentally determined properties, more work needs to be done to determine 
whether the rate of recovery of molecular permeability is equal to that of ionic permeability. Currently 
the model is limited to the use of empirical relationships from experimental results produced using 
specific conditions. 
The development of this model did explicitly show that the electrode configuration plays a critical role 
in the success of the cellular uptake of the drug. It is also shown that a periodic electroporation regime 
can be implemented in order to offset the effects of pore resealing and that in our study, this results in 
five times the drug delivery (compared to a single pulse). It is also shown that the clamped electrode 
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configuration provides a larger region of reversible electroporation compared to the side-by-side 
arrangement. 
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